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90The role of advanced diagnostic technology in
the selection of a patient with symptomatic but
hemodynamically insignificant disease for carotid
endarterectomy
Kristine Clodfelter Orion, MD, Jenna Ruppert, RDMS, RVT, Diana Call, RVT, Mahmoud Malas, MD,
Kristen Piazza, PA-C, and Bruce A. Perler, MD, MBA, Baltimore, Md
Current Level I evidence demonstrates no benefit for carotid endarterectomy in symptomatic patients with <50% carotid
stenoses. However, unstable plaque morphology is increasingly recognized in the genesis of ischemic cerebral events. New
advanced imaging technology, such as contrast-enhanced magnetic resonance angiography and ultrasound imaging, are
emerging as important adjuncts in the evaluation of this patient population. We present a case where both modalities were
beneficial in identifying plaque instability manifested by intraplaque hemorrhage and neovascularization in a patient with
recurrent cerebral ischemic events and hemodynamically insignificant carotid disease. (J Vasc Surg Cases 2015;1:90-3.)Level I evidence derived from the North American
Symptomatic Carotid Endarterectomy Trial1 and the
European Carotid Surgery Trial2 established the role of ca-
rotid endarterectomy (CEA) for patients with symptomatic
>50% internal carotid artery (ICA) stenoses. Conversely,
these investigations demonstrated no benefit for CEA for
symptomatic patients with <50% stenoses compared with
medical management. We recently encountered a patient
with a unilateral hemodynamically insignificant ICA steno-
sis who experienced recurrent cerebral ischemic events
despite maximum medical therapy and without other
potential causes. On the basis of magnetic resonance angi-
ography (MRA) and contrast-enhanced duplex findings,
we proceeded with CEA. This case illustrates that rarely
one may encounter a patient with an unstable plaque in
the absence of hemodynamic significance and who should
be managed with CEA. The patient consented to publica-
tion of this report.
CASE REPORT
A 72-year-old man was referred to vascular surgery by his
neurologist after three separate cerebral vascular accidents. Histhe Division of Vascular Surgery and Endovascular Therapy, The
hns Hopkins Medical Institutions.
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://dx.doi.org/10.1016/j.jvsc.2015.03.002medical history was significant for coronary artery disease, hyper-
tension, and hyperlipidemia. His first stroke was in 2007 and was
manifested by right-sided weakness, slurred speech, and Wernicke
aphasia. He received tissue plasminogen activator and he improved
over the course of 3 months. He was found to have insignificant
carotid disease. His second stroke occurred in January 2014 and
was manifested by right-sided weakness and difficulty walking.
Three months later in April, he experienced a third stroke with
similar physical presentation. A carotid duplex examination at
that time demonstrated bilateral <50% ICA stenoses.
The patient underwent a cardiology evaluation, with no
obvious cardiac source found. He underwent conventional mag-
netic resonance imaging (MRI)/MRA evaluation, which revealed
several strokes in the left middle cerebral artery (MCA) territory
as well as in the left anterior communicating artery/MCA and
MCA/posterior communicating artery watershed areas. Computed
tomography angiography demonstrated calcified irregular plaque at
both carotid bifurcations.
He then was referred for a repeat MRA using T1-weighted
black blood images after gadolinium administration, which
demonstrated a left carotid plaque with intraplaque hemorrhage
(IPH), an enhancing fibrous cap, and an ulcer (Fig 1). This tech-
nique is designed specifically for the carotid to minimize the flow
artifacts generated from recirculating flow in the bulb and uses a
dedicated neck coil for carotid imaging.
He was referred for consideration of CEA. The patient’s baseline
neurologic examination consisted of mild dysarthria, 3/5 strength in
his right arm, and 4/5 strength in his right leg. A repeat conventional
duplex scan in our Intersocietal Accreditation Commission-
accredited vascular laboratory revealed a <50% left ICA stenosis
based on a peak systolic velocity of 104 cm/s, end-diastolic velocity
of 13 cm/s, and an ICA/common carotid artery ratio of 1.0. Our
diagnostic criteria for this nonsignificant ICA stenosis are: no spectral
broadening with peak systolic velocity of <140 cm/s, end-diastolic
velocity of <100 cm/s, and an ICA/common carotid artery ratio
of <2.0. It also showed a suspicious primarily echolucent plaque
with only the anterior surface being echogenic.
Fig 1. Magnetic resonance imaging (MRI)/magnetic resonance angiography (MRA). a, Common, internal, and
external carotid arteries. b, Axial reconstructions of three-dimensional high-resolution blood and calcium gradient-echo
sequence. The dark yellow arrow indicates calcification, and the light yellow arrow indicates hemorrhagic plaque. c,
Two-dimensional high-resolution cardiac-gated T1-weighted black blood MRI postcontrast. Green indicates fibrous
cap, light yellow indicates the central lipid core, and turquoise indicates adventitial enhancement, a marker of
neovascularization.
Fig 2. Left, Preoperative contrast-enhanced duplex scan of the internal carotid artery (ICA). The yellow arrow in-
dicates echogenic plaque and lipid core, and the red arrow indicates the vasa vasorum and contrast-enhanced hem-
orrhage within the plaque. Right, Preoperative duplex scan without contrast enhancement.
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carotid duplex examination after infusing OPTISON (Perflutren
Protein-Type A Microspheres Injectable Suspension, USP; GE
Healthcare, Waukesha, Wisc) in the preoperative holding unit. Asignificant area of the vasa vasorum was illuminated within a large
irregular plaque suggestive of IPH (Fig 2).
In the absence of other potential etiologies for his recurrent
strokes, he consented to undergo left CEA. An uneventful left
Fig 3. Operative findings. Note hemorrhagic plaque.
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thesia with the use of an intraluminal shunt. The dissection was
carried distally and proximally using sharp and blunt dissection.
The carotid bulb was very soft and mildly dilated, with thinned
adventitia and lipid-colored underlying plaque. We estimated the
degree of stenosis approached 50%. Great care was taken to not
disturb the bulb in the dissection. We identified a large lipid-
laden hemorrhagic plaque (Fig 3).
A conventional CEA was performed, and the artery repaired
with a Dacron (DuPont, Wilmington, Del) patch. A completion
carotid duplex scan demonstrated normal flow velocities in the
left common, internal, and external carotid arteries.
The patient was then awoken from general anesthesia. He
exhibited temporary weakness and dysarthria, but this returned
to his baseline #15 minutes. A neurology consult was requested,
and they agreed that he did not have a temporary ischemic acci-
dent but that his symptoms were more consistent with “stunned
brain” after CEA in a symptomatic patient. A head computed to-
mography scan did not show any additional findings. The
remainder of his postoperative course was uneventful, and he
was discharged home to his family the next day.
DISCUSSION
The anatomic severity of a carotid stenosis has been the
primary metric for defining the indications for CEA. Level I
evidence supports intervention for symptomatic patients
with a >50% stenosis. Rarely, however, clinicians encounter
patients with symptomatic disease and <50% stenoses. Pre-
vious studies have indicated that echolucent plaques with
abundant lipid and inflammatory cell content may be unsta-
ble and more vulnerable to rupture.3-5 As a result of the
decreased collagen formation and increased collagen degra-
dation, the plaque’s thin fibrous cap is more easily disrupted
by the increasing wall shear stress.6
To better identify these high-risk plaques, MRI has
been used to evaluate plaque morphology. Specifically,
IPH can be difficult to distinguish from a lipid core on con-
ventional T1- or T2-weighted images.7 Many have argued
that the accuracy is improved when time of flight is added.8However, Wasserman et al9 of our institution demon-
strated that the use of a mask sequence at 3 T revealed
higher specificity compared by those with 1.5 T for IPH
detection. Even further, ulceration can be easily distin-
guished from IPH with this technique. We found that
technology very informative in this case. In fact, Altaf
et al10 prospectively analyzed the recurrence of ischemic
events in patients with symptomatic mild stenosis (30%-
49%) and found that during a 28-month period, MRI
detected IPH in 25% of these patients. Similarly, among
symptomatic patients with low-grade carotid stenoses,
Yoshida et al11 found ischemic recurrence in 44% of medi-
cally treated patients with a high-signal plaque during a 16-
month period. When Wasserman et al12 studied 47 patients
in vivo, they demonstrated that IPH and neovascularity are
both independently associated with previous cerebrovascu-
lar events.
Neovascularization is proposed to precede the develop-
ment of increased intima-media thickness and therefore
atherosclerosis at its earliest stage of development.13,14
To further develop the recognition of neovascularity,
contrast-enhanced ultrasound has recently emerged as a
valuable advancement in carotid artery surveillance. The
adjunctive contrast is used to identify neovascularization
within the adventitial layer.13 The contrast is well tolerated
by patients, and because of the incorporation of three-
dimensional imaging, the need for operator-dependent
probe maneuvers to capture three planes is eliminated.
This technology clearly represents another tool to
more accurately characterize plaque morphology. We
believe it may provide another means of identifying patients
with asymptomatic carotid disease who would be at
increased risk of stroke and therefore candidates for CEA.
One can only speculate, and further study will be required,
to determine if this technology might allow better case se-
lection of patients for carotid stenting vs CEA.
CONCLUSIONS
Evidence is accumulating that plaque morphology
indicative of plaque instability, including echolucency, ul-
ceration, or the presence of IPH, should be considered
when offering CEA to a patient with symptomatic low-
grade stenosis. Although most patients who present with
morphologic plaque features indicative of plaque instability
tend to be severely stenotic, infrequently one will
encounter a patient with hemodynamically insignificant
disease without the conventional accepted anatomic indica-
tions for intervention but in whom an unstable plaque is
etiologically responsible for stroke. The current case illus-
trates how contrast-enhanced MRA and ultrasound exam-
inations can help identify appropriate candidates for carotid
intervention in the absence of hemodynamically significant
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